A Randomized Phase II Study of Paclitaxel-carboplatin-bevacizumab With or Without Nitroglycerin Patches in Patients With Stage IV Non-squamous-non-small Cell Lung Cancer: NVALT12
Latest Information Update: 08 Nov 2021
At a glance
- Drugs Nitroglycerin (Primary) ; Bevacizumab; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms NVALT-12
- 09 Sep 2019 Results of post hoc analysis investigating the potential of skeletal muscle radiomic features to predict future muscle loss published in the European Journal of Cancer
- 14 Jan 2019 Results published in the Clinical Cancer Research
- 14 Jan 2019 Status changed to completed as per results published in the Clinical Cancer Research